Iskanje po repozitoriju

A+ | A- | | SLO | ENG

Povzetek: Hymenoptera venom allergy is one of the most severe allergic diseases, with a considerable prevalence of anaphylactic reaction, making it potentially lethal. In this review, we provide an overview of the current knowledge and recent findings in understanding induced immune mechanisms during different phases of venom immunotherapy. We focus on protection mechanisms that occur early, during the build-up phase, and on the immune tolerance, which occurs later, during and after Hymenoptera venom immunotherapy. The short-term protection seems to be established by the early desensitization of mast cells and basophils, which plays a crucial role in preventing anaphylaxis during the build-up phase of treatment. The early generation of blocking IgG antibodies seems to be one of the main reasons for the lower activation of effector cells. Long-term tolerance is reached after at least three years of venom immunotherapy. A decrease in basophil responsiveness correlates with tolerated sting challenge. Furthermore, the persistent decline in IgE levels and, by monitoring the cytokine profiles, a shift from a Th2 to Th1 immune response, can be observed. In addition, the generation of regulatory T and B cells has proven to be essential for inducing allergen tolerance. Most studies on the mechanisms and effectiveness data have been obtained during venom immunotherapy (VIT). Despite the high success rate of VIT, allergen tolerance may not persist for a prolonged time. There is not much known about immune mechanisms that assure longterm tolerance post-therapy.
Ključne besede: allergy and immunology, hypersensitivity, immunotherapy, immune tolerance, venoms, Hymenoptera, Hymenoptera venom, short-term protection, long-term tolerance
Objavljeno v DiRROS: 16.08.2021; Ogledov: 885; Prenosov: 282
Povezava na datoteko

Povzetek: Background: Hypoxia correlates with poor prognosis in several cancer types, including lung cancer. Prolyl hydroxylase domain proteins (PHDs) play a role in cell oxygen sensing, negatively regulating the hypoxia-inducible factor (HIF) pathway. Our study aim was to evaluate PHD1, PHD2 and PHD3 mRNA expression levels in primary tumours and normal lungs of non-small-cell lung cancer (NSCLC) patients and to correlate it with selected regulators of HIF signalling, with clinicopathological characteristics and overall survival (OS). Methods: Tumour tissue samples were obtained from 60 patients with surgically resected NSCLC who were treated with radical surgery. In 22 out of 60 cases, matching morphologically normal lung tissue was obtained. PHD1, PHD2 and PHD3 mRNA expressions were measured using RT-qPCR. Results: The PHD1 and PHD2 mRNA levels in primary tumours were significantly decreased compared to those in normal lungs (both p < 0.0001). PHD1 and PHD2 expression in tumours was positively correlated (rs = 0.82; p < 0.0001) and correlated well with HIF pathway downstream genes HIF1A, PKM2 and PDK1. Decreased PHD1 and PHD2 were associated with larger tumour size, higher tumour stage (PHD1 only) and squamous cell carcinoma. Patients with low PHD1 and patients with low PHD2 expression had shorter OS than patients with high PHD1 (p = 0.02) and PHD2 expression (p = 0.01). PHD1 showed borderline independent prognostic values in multivariate analysis (p = 0.06). In contrast, we found no associations between PHD3 expression and any of the observed parameters. Conclusions: Our results show that reduced expression of PHD1 and PHD2 is associated with the development and progression of NSCLC. PHD1 could be further assessed as a prognostic marker in NSCLC.
Ključne besede: non-small-cell lung carcinoma, prognosis, non-small cell lung cancer, mRNA expression, prolyl hydroxylase domain proteins
Objavljeno v DiRROS: 21.05.2021; Ogledov: 1223; Prenosov: 877
Celotno besedilo (820,49 KB)
Gradivo ima več datotek! Več...

Povzetek: Modeli razvoja gozdov napovedujejo razvoj dreves in gozdnih sestojev glede na drevesne, sestojne, rastiščne in gozdnogospodarske dejavnike. Zaradi kompleksne narave gozdnih ekosistemov in dolgih proizvodnih ciklov je modeliranje razvoja gozdov pomemben sestavni del upravljanja gozdov. Sestojni modeli so bili prepoznani kot primerni za podporo odločanju pri upravljanju z gozdovi. Primer takega modela je švicarski model SiWaWa, ki smo ga preizkusili v pričujoči raziskavi. Na štirih vzorcih po 50 stalnih vzorčnih ploskev v negospodarjenih in gospodarjenih čistih bukovih in čistih smrekovih enomernih sestojih smo izvedli simulacije razvoja gozdov za obdobje 10 let, nato pa smo primerjali dejanske vrednosti in modelske napovedi za sestojno temeljnico G, število dreves N in srednje temeljnični premer Dg. Napovedovanje razvoja čistih bukovih gozdov je bilo zadovoljivo točno; v negospodarjenih sestojih je celotna napaka RMSE za sestojno temeljnico znašala 2,35 m2 /ha, v gospodarjenih sestojih pa 3,42 m2/ha ob upoštevanju le posekanih dreves in 4,35 m2/ha ob upoštevanju celotne mortalitete. Enako ne moremo trditi za napovedovanje razvoja čistih smrekovih sestojev. Pri slednjih so bile mere točnosti znatno slabše, saj so RMSE za napovedano sestojno temeljnico znašali 8,94 m2/ha za negospodarjene in 6,13 m2/ha ter 6,11 m2/ha za gospodarjene sestoje ob upoštevanju poseka oziroma celotne mortalitete. Model SiWaWa, ki je parametriziran za švicarske gozdove, se zdi uporaben za simuliranje razvoja čistih bukovih gozdov brez simuliranega ukrepanja (poseka) ali z njim. Zanesljive simulacije razvoja čistih smrekovih sestojev pa model zaenkrat še ne omogoča.
Ključne besede: model razvoja gozdov, gozdni sestoj, gozdna inventura, simulacije razvoja gozdov, sestojna temeljnica, število dreves, srednje temeljnični premer
Objavljeno v DiRROS: 08.03.2021; Ogledov: 1591; Prenosov: 490
Celotno besedilo (426,06 KB)

Povzetek: Background: The role of chemokines in anaphylaxis is unclear. Methods: We prospectively recruited 49 patients presenting to the emergency department with an acute episode of anaphylaxis and 28 healthy subjects. We measured serum levels of the chemokines CCL2, CCL5, CCL7, CCL8, CCL11, CCL13, CCL17, CCL21, CCL22, CCL24, and CCL26, tryptase, the absolute number of circulating basophils, monocytes, lymphocytes, and PMNs, and whole blood FCER1A, CPA3 and HDC gene expression at two time points: during the anaphylactic episode and in convalescent samples collected approximately 3 months later. We then investigated the in vitro chemotactic activity of chemokines induced during anaphylaxis for the in vitro migration of the corresponding cells. Results: Only CCL2 chemokine levels were signifcantly increased in anaphylaxis samples (median 514 pg/ml) compared to convalescent samples (284 pg/ml, P<0.0001) and healthy subjects (279 pg/ml, P<0.0001); there was no signifcant diference in any of the other chemokines. There was a signifcant positive correlation between the rates of increase of serum CCL2 (median [range]: 106.0% [-44.7% to 557.4%]) and tryptase (133.8% [-6.6% to 893.4%]; r=0.68, P<0.0001) and between the acute concentration of serum CCL2 and the acute concentration of serum tryptase (r=0.77, P<0.0001). The number of circulating basophils, but not other blood cells, signifcantly decreased during anaphylaxis (median 5.0 vs. 19.1 cells/[micro]l in convalescent samples; P<0.0001); a decrease in whole-blood gene expression of basophil markers (PKljučne besede: anaphylaxis, chemokines, tryptases, basophils, chemotaxis, CCL2, cell migration
Objavljeno v DiRROS: 18.01.2021; Ogledov: 1365; Prenosov: 633
Celotno besedilo (2,04 MB)

Povzetek: Hereditary angioedema (HAE) is a rare autosomal dominant disease with deficiency (type I) or dysfunction (type II) of C1 inhibitor, caused by mutations in the C1-INH gene, characterized by recurrent submucosal or subcutaneous edemas including skin swelling, abdominal pain and life-threatening episodes of upper airway obstruction. The aim of this study was to investigate healthcare experiences in children with HAE due to C1 inhibitor deficiency (C1-INH-HAE) in Croatia in order to estimate the number of affected children and to recommend management protocols for diagnosis, short-term prophylaxis and acute treatment. Patients were recruited during a 4-year period at five hospitals in Croatia. Complement testing was performed in patients with a positive family history. This pilot study revealed nine pediatric patients positive for C1-INH- HAE type I, aged 1-16 years, four of them asymptomatic. Before the age of one year, C1-INH levels may be lower than in adults; it is advisable to confirm C1-INH-HAE after the age of one year. Plasma-derived C1- INH is recommended as acute and short-term prophylactic treatment. Recombinant C1-INH and icatibant are licensed for the acute treatment of pediatric patients. In Croatia, HAE is still underdiagnosed in pediatric population.
Ključne besede: hereditary angioedemas -- genetics -- Croatia, inborn genetic diseases -- Croatia, pediatrics -- Croatia, C1 inhibitor, SERPING1 gene, children
Objavljeno v DiRROS: 16.12.2020; Ogledov: 1244; Prenosov: 972
Celotno besedilo (477,81 KB)
Gradivo ima več datotek! Več...